About Us

Transforming Through Cellular Innovation

What We Do?

At CytoHub, our team brings together a rich blend of expertise, uniting traditional drug development and biopharmaceutical acumen with future-focused disciplines such as AI, Machine Learning, Cloud Computing and Smart Manufacturing. This multidisciplinary approach empowers us to drive our audacious mission forward: reinventing the process of cell and gene therapy drug, development and manufacturing for a healthier future.

Advisors

Rahul Singhvi, ScD

Co-Founder, National Resilience

Prof. Vish Krishnan

Business Management Advisor; Professor and Chair at UCSD

Mohammad El-Kalay, PhD

Manufacturing and TechOps Advisor

Team

Rajib Biswas, PhD

Co-Founder, CEO & Chairman

Frank Teoh, MS

Co-Founder, VP of Engineering & Global Head of BioEngineAI Platform

Aitor Aguirre, PhD

Co-Founder, Head of R&D

Richard Anderson, PhD

VP of TechOps

Diane Caballa

Sr. Process Engineer

Nagasoujanya Annasamudram, PhD

ML Engineer

Matthieu Bauer, PhD

Principal Scientist

Boyoon Choi, JD, MBA

General Counsel & Corporate Strategy

Erez Pery, PhD

Cell Based Assays

Satish Kumar, PhD

Lead AI/ML Engineer, BioEngineAI Platform

Mudit Kakar, PhD, JD

Head, Intellectual Property & Strategy

Oscar J. Abilez, MD, PhD

CM Organoids

Our Mission

CytoHub is at the forefront of cardiac drug discovery and regenerative medicine, pioneering AI-driven human mini-heart technology to revolutionize drug screening and discovery, disease modeling, and clinical application in heart muscle regeneration.

Our Vision

Our vision is to revolutionize the landscape of cell therapy and regenerative medicine through innovative biomanufacturing solutions, i.e., “Crafting Cells for Cures”.